Chemoselective Hydrogenation of 6-Alkynyl-3-fluoro-2-pyridinaldoximes: Access to First-in-Class 6-Alkyl-3-Fluoro-2-pyridinaldoxime Scaffolds as New Reactivators of Sarin-Inhibited Human Acetylcholinesterase with Increased Blood-Brain Barrier Permeability.


Journal

Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783

Informations de publication

Date de publication:
20 Nov 2020
Historique:
received: 24 04 2020
pubmed: 8 7 2020
medline: 17 2 2021
entrez: 8 7 2020
Statut: ppublish

Résumé

Novel 6-alkyl- and 6-alkenyl-3-fluoro-2-pyridinaldoximes have been synthesised by using a mild and efficient chemoselective hydrogenation of 6-alkynyl-3-fluoro-2-pyridinaldoxime scaffolds, without altering the reducible, unprotected, sensitive oxime functionality and the C-F bond. These novel 6-alkyl-3-fluoro-2-pyridinaldoximes may find medicinal application as antidotes to organophosphate poisoning. Indeed, one low-molecular-weight compound exhibited increased affinity for sarin-inhibited acetylcholinesterase (hAChE) and greater reactivation efficiency or resurrection for sarin-inhibited hAChE, compared with those of 2-pyridinaldoxime (2-PAM) and 1-({[4-(aminocarbonyl)pyridinio]methoxy}methyl)-2-[(hydroxyimino)methyl]pyridinium chloride (HI-6), two pyridinium salts currently used as antidote by several countries. In addition, the uncharged 3-fluorinated bifunctional hybrid showed increased in vitro blood-brain barrier permeability compared with those of 2-PAM, HI-6 and obidoxime. These promising features of novel low-molecular-weight alkylfluoropyridinaldoxime open up a new era for the design, synthesis and discovery of central non-quaternary broad spectrum reactivators for organophosphate-inhibited cholinesterases.

Identifiants

pubmed: 32633095
doi: 10.1002/chem.202002012
doi:

Substances chimiques

Cholinesterase Inhibitors 0
Cholinesterase Reactivators 0
Oximes 0
Pyridinium Compounds 0
pyridine-2-aldoxime 8PN0640Z70
Sarin B4XG72QGFM
Acetylcholinesterase EC 3.1.1.7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15035-15044

Subventions

Organisme : Agence Nationale de la Recherche ANR
ID : ANR 15-CE39-0012
Organisme : Agence Nationale de la Recherche
ID : 17-CE39-0012-01
Organisme : Direction Générale de l'Armement (DGA) and Service de Santé des Armées (SSA) of the French Ministry of Armed Forces
ID : NBC-5-C-4210

Informations de copyright

© 2020 Wiley-VCH GmbH.

Références

C. M. Timperley, J. E. Forman, M. Abdollahi, A. S. Al-Amri, A. Baulig, D. Benachour, V. Borrett, F. A. Cariño, M. Geist, D. Gonzalez, W. Kane, Z. Kovarik, R. Martínez-Álvarez, N. M. Fusaro Mourão, S. Neffe, S. K. Raza, V. Rubaylo, A. G. Suárez, K. Takeuchi, C. Tang, F. Trifirò, F. Mauritz van Straten, P. S. Vanninen, S. Vučinić, V. Zaitsev, M. Zafar-Uz-Zaman, M. S. Zina, S. Holen, Toxicology 2019, 415, 56-59.
 
D. E. Lorke, G. A. Petroianu, Front. Neurosci. 2019, 13, 1-13;
E. J. Mew, P. Padmanathan, F. Konarasen, M. Eddlestion, S.-S. Chang, M. R. Phillips, D. Gunnel, J. Affective Disord. 2017, 219, 93-104.
R. C. Gupta in Toxicology of Organophosphate and Carbamate Compounds (Ed.: R. C. Gupta), Elsevier Academic Press, Massachusetts, 2006a, pp. 5-24.
 
E. Antonijevic, J. Kotur-Stevuljevic, K. Musilek, A. Kosvancova, K. Kuca, D. Djukic-Cosic, V. Spasojevic-Kalimanovska, B. Antonijevic, Arch. Toxicol. 2018, 92, 745-757;
G. A. Petroianu, Pharmazie 2014, 69, 780-784;
T. Myhrer, P. Aas, Neurosci. Biobehav. Rev. 2016, 71, 657-670;
P. Masson, F. Nachon, J. Neurochem. 2017, 142, 26-40;
J. Kassa, C. M. Timperley, M. Bird, R. L. Williams, A. C. Gree, J. E. H. Tattersall, Toxicology 2018, 408, 95-100.
 
G. Mercey, T. Verdelet, J. Renou, M. Kliachyna, R. Baati, F. Nachon, L. Jean, P.-Y. Renard, Acc. Chem. Res. 2012, 45, 756-766;
A. J. Franjesevic, S. B. Sillart, J. M. Beck, S. Vyas, S. Christopher, C. M. Hadad, Chem. Eur. J. 2019, 25, 5337-5371;
S. Costanzi, J. H. Machado, M. Mitchell, ACS Chem. Neurosci. 2018, 9, 873-885;
F. Worek, H. Tielmann, T. Wille, Arch. Toxicol. 2020, 94, 2275-2292.
 
F. Eyer, V. Meischner, D. Kiderlen, H. Thiermann, F. Worek, M. Haberkorn, Toxicol. Rev. 2003, 22, 143-163;
M. Balali-Mood, K. Balali-Mood, Arch. Iran. Med. 2008, 11, 65-89;
G. Petroianu, L. M. Toomes, A. Petroianu, W. Bergler, R. Rufer, J. Appl. Toxicol. 1998, 18, 293-298;
G. A. Petroianu, Eur. J. Emerg. Med. 2005, 12, 102-103;
B. Antonijevic, M. P. Stojiljkovic, Clin. Med. Res. 2007, 5, 71-82;
H. Hrabetz, H. Thiermann, N. Felgenhauer, T. Zilker, B. Haller, J. Nahrig, Chem.-Biol. Interact. 2013, 206, 561-568.
F. Worek, H. Thiermann, T. Wille, Chem.-Biol. Interact. 2016, 259, 93-98.
 
M. Kloske, Z. Witkiewicz, Chemosphere 2019, 221, 672-682;
J. A. Vale, T. C. Marrs, R. L. Maynard, Clin. Toxicol. 2018, 56, 1093-1097;
T. C. C. Franca, D. A. S. Kitagawa, S. F. de A. Cavalcante, J. A. V. da Silva, E. Nepovimova, K. Kuca, Int. J. Mol. Sci. 2019, 20, 1222;
K. Kuca, E. Nepovimova, Australasian Med. J. 2019, 12, 49-52.
 
L. Louise-Leriche, E. Pàunescu, G. Saint-André, R. Baati, A. Romieu, A. Wagner, P. Y. Renard, Chem. Eur. J. 2010, 16, 3510-3523;
G. Saint-André, M. Kliachyna, S. Kodepelly, L. Louise-Leriche, E. Gillon, P. Y. Renard, F. Nachon, R. Baati, A. Wagner, Tetrahedron 2011, 67, 6352-6361.
 
G. Mercey, T. Verdelet, G. Saint-Andre, E. Gillon, A. Wagner, R. Baati, L. Jean, F. Nachon, P. Y. Renard, Chem. Commun. 2011, 47, 5295-5297;
G. Mercey, J. Renou, T. Verdelet, M. Kliachyna, R. Baati, E. Gillon, M. Arboleas, M. Loiodice, F. Nachon, L. Jean, P. Y. Renard, J. Med. Chem. 2012, 55, 10791-10795;
J. Renou, G. Mercey, T. Verdelet, E. Paunescu, E. Gillon, M. Arboleas, M. Loiodice, M. Kliachyna, R. Baati, F. Nachon, L. Jean, P. Y. Renard, Chem.-Biol. Interact. 2013, 203, 81-84;
J. Renou, M. Loiodice, M. Arboleas, R. Baati, L. Jean, F. Nachon, P. Y. Renard, Chem. Commun. 2014, 50, 3947-3950;
M. Kliachyna, G. Santoni, V. Nussbaum, J. Renou, B. Sanson, J. P. Colletier, M. Arboléas, M. Loiodice, M. Weik, L. Jean, P. Y. Renard, F. Nachon, R. Baati, Eur. J. Med. Chem. 2014, 78, 455-467;
J. Renou, J. Dias, G. Mercey, T. Verdelet, C. Rousseau, A. J. Gastellier, M. Arboleas, M. Touvrey-Loiodice, R. Baati, L. Jean, F. Nachon, P. Y. Renard, RSC Adv. 2016, 6, 17929-17940;
A.-G. Calas, A.-S. Hanak, N. Jaffré, A. Nervo, J. Dias, C. Rousseau, C. Courageux, X. Brazzolotto, P. Villa, A. Obrecht, J.-F. Goossens, C. Landry, J. Hachani, F. Gosselet, M.-P. Dehouck, J. Yerri, M. Klyachina, R. Baati, F. Nachon, Biomolecules 2020, 10, 858.
 
T. Zorbaz, A. Braïki, N. Maraković, J. Renou, E. de la Mora, N. Maček Hrvat, M. Katalinić, I. Silman, J. L. Sussman, G. Mercey, C. Gomez, R. Mougeot, B. Pérez, R. Baati, F. Nachon, M. Weik, L. Jean, Z. Kovarik, P. Y. Renard, Chem. Eur. J. 2018, 24, 9675-9691;
G. Santoni, J. de Sousa, E. de la Mora, J. Dias, L. Jean, J. L. Sussman, I. Silman, P. Y. Renard, R. C. D. Brown, M. Weik, R. Baati, F. Nachon, J. Med. Chem. 2018, 61, 7630-7639.
 
M. C. de Koning, M. van Grol, D. Noort, Tox. Lett. 2011, 206, 54-59;
M. C. de Koning, M. J. A. Joosen, F. Worek, F. Nachon, M. van Grol, S. D. Klaassen, D. P. W. Alkema, T. Wille, H. M. de Bruijn, J. Med. Chem. 2017, 60, 9376-9392.
 
T. Zorbaz, D. Malinak, N. Maraković, N. Maček Hrvat, A. Zandona, M. Novotny, A. Skarka, R. Andrys, M. Benkova, O. Soukup, M. Katalinić, K. Kuca, Z. Kovarik, K. Musilek, J. Med. Chem. 2018, 61, 10753-10766;
T. Zorbaz, D. Malinak, K. Kuca, K. Musilek, Z. Kovarik, Chem.-Biol. Interact. 2019, 307, 16-20.
 
F. S. Katz, S. Pecic, T. H. Tran, I. Trakht, L. Schneider, Z. Zhu, L. Ton-That, M. Luzac, V. Zlatanic, S. Damera, J. Mac Donald, D. W. Landry, L. Tong, M. N. Stojanovic, ChemBioChem 2015, 16, 2205-2215;
M. C. de Koning, G. Horn, F. Worek, Eur. J. Med. Chem. 2018, 157, 151-160;
C. Linn Cadieux, H. Wang, Y. Zhang, J. A. Koenig, T. M. Shih, J. Mac Donough, J. Koh, D. Cerasoli, Chem.-Biol. Interact. 2016, 259, 133-141.
 
K. Muller, C. Faeh, F. Diederich, Science 2007, 317, 1881-1886;
P. Kirsch, Modern Fluoroorganic Chemistry: Synthesis Reactivity, Applications, 2nd ed., Wiley-VCH, Weinheim, 2013;
J. Wang, M. Sanchez-Rosello, J. Acenă, C. Del Pozo, A. E. Sorochinsky, S. Fustero, V. A. Soloshonok, H. Liu, Chem. Rev. 2014, 114, 2432-2506;
E. P. Gillis, K. J. Eastman, M. D. Hill, D. J. Donnelly, N. A. Meanwell, J. Med. Chem. 2015, 58, 8315-8359;
S. Purser, P. R. Moore, S. Swallow, V. Gouverneur, Chem. Soc. Rev. 2008, 37, 320-330;
W. K. Hagmann, J. Med. Chem. 2008, 51, 4359-4369;
N. A. Meanwell, J. Med. Chem. 2011, 54, 2529-2591.
 
M. Timperley, R. E. Banks, I. M. Young, R. N. Haszeldine, J. Fluorine Chem. 2011, 132, 541-547;
H. C. Jeong, N. S. Kang, N. J. Park, E. K. Yumb, Y. S. Jung, Bioorg. Med. Chem. Lett. 2009, 19, 1214-1217;
H. C. Jeong, N. S. Kang, N. J. Park, E. K. Yum, Y. S. Jung, Bioorg. Med. Chem. 2009, 17, 6213-6217.
Y. Jagadeesh, R. Baati, Eur. J. Org. Chem. 2018, 4161-4165.
 
K. D. Baucom, A. S. Guram, C. J. Borths, Synlett 2015, 26, 201-204;
I. Tsukamoto, H. Koshio, T. Kuramochi, C. Saitoh, H. Yanai-Inamura, C. Kitada-Nozawa, E. Yamamoto, T. Yatsu, Y. Shimada, S. Sakamoto, S. I. Tsukamoto, Bioorg. Med. Chem. 2009, 17, 3130-3141.
 
D. Uredi, D. Reddy Motati, E. B. Watkins, Chem. Commun. 2019, 55, 3270;
T. J. Donohoe, C. R. Jones, A. F. Kornahrens, L. C. Barbosa, L. J. Walport, M. R. Tatton, M. O'Hagan, A. H. Rathi, D. B. Baker, J. Org. Chem. 2013, 78, 12338-12350;
P. Fu, S. Wang, K. Hong, X. Li, P. Liu, Y. Wang, W. Zhu, J. Nat. Prod. 2011, 74, 1751-1756;
Z. Song, X. Huang, W. Yi, W. Zhang, Org. Lett. 2016, 18, 5640-5643.
The chemical synthesis of 14 is described in the Experimental Section.
R. Cecchelli, S. Aday, E. Sevin, C. Almeida, M. Culot, L. Dehouck, C. Coisne, B. Engelhardt, M. P. Dehouck, L. Ferreira, PLoSOne 2014, 9.
D. C. Pedroso, A. Tellechea, L. Moura, I. Fidalgo-Carvalho, J. Duarte, E. Carvalho, L. Ferreira, PLoS One 2011, 6.
A. Siflinger-Birnboim, P. J. Del Vecchio, J. A. Cooper, F. A. Blumenstock, J. M. Shepard, A. B. Malik, J. Cell Physiol. 1987, 132, 111-117.
S. Gustafsson, V. Lindström, M. Ingelsson, M. Hammarlund-Udenaes, S. Syvänen, Neuropharmacology 2018, 128, 482-491.
B. M. Best, S. L. Letendre, E. Brigid, D. B. Clifford, A. C. Collier, B. B. Gelman, J. C. McArthur, J. A. Mc Cutchan, D. M. Simpson, R. Ellis, E. V. Capparelli, I. Grant, AIDS 2009, 23, 83-87.

Auteurs

Jagadeesh Yerri (J)

ICPEES UMR CNRS 7515, Institut de Chimie des Procédés, pour l'Energie, l'Environnement, et la Santé, 25 Rue Becquerel, 67087, Strasbourg, France.

José Dias (J)

Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées, 91220, Brétigny-sur-Orge, France.

Mallikajurna Reddy Nimmakayala (MR)

ICPEES UMR CNRS 7515, Institut de Chimie des Procédés, pour l'Energie, l'Environnement, et la Santé, 25 Rue Becquerel, 67087, Strasbourg, France.

Franck Razafindrainibe (F)

ICPEES UMR CNRS 7515, Institut de Chimie des Procédés, pour l'Energie, l'Environnement, et la Santé, 25 Rue Becquerel, 67087, Strasbourg, France.

Charlotte Courageux (C)

Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées, 91220, Brétigny-sur-Orge, France.

Anne-Julie Gastellier (AJ)

Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées, 91220, Brétigny-sur-Orge, France.

Johanne Jegoux (J)

Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées, 91220, Brétigny-sur-Orge, France.

Caroline Coisne (C)

UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Université d'Artois (UArtois), 62307, Lens, France.

Christophe Landry (C)

UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Université d'Artois (UArtois), 62307, Lens, France.

Fabien Gosselet (F)

UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Université d'Artois (UArtois), 62307, Lens, France.

Johan Hachani (J)

UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Université d'Artois (UArtois), 62307, Lens, France.

Jean-François Goossens (JF)

ULR 7365-GRITA-Groupe de Recherche sur les Formes, Injectables et Technologies Associées, University of Lille, 59000, Lille, France.

Marie-Pierre Dehouck (MP)

UR 2465, Laboratoire de la Barrière Hémato-Encéphalique (LBHE), Université d'Artois (UArtois), 62307, Lens, France.

Florian Nachon (F)

Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées, 91220, Brétigny-sur-Orge, France.

Rachid Baati (R)

ICPEES UMR CNRS 7515, Institut de Chimie des Procédés, pour l'Energie, l'Environnement, et la Santé, 25 Rue Becquerel, 67087, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH